Sanofi-Aventis to strengthen joint R&D with Korean partners

Published: 2009-06-18 06:58:00

Updated: 2009-06-18 06:58:00

Sanofi-Aventis, a French-based pharmaceutical company, plans to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in the related therapeutic sectors.

For technique exchange and information sharing, Sanofi-Aventis, the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK